Alira Health enhances its market access services through a strategic partnership with Centivis

Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital diagnostic solutions.

With the rise of precision medicine, our pharma and medtech partners require more dedicated access solutions for in-vitro and digital diagnostics solutions. We believe that Centivis’ specialization in this field is particularly suited to the needs of the market.”
Jean-Francois Ricci Chief Access Officer, Alira Health

“We are honored to join forces with Centivis, an up-and-coming niche provider in the space with deep insight into the nuances of diagnostics access models,” said Richard Charter, Alira Health’s Vice President of MedTech Market Access for Europe & Asia Pacific.

“The diagnostics industry is transforming rapidly. More complex solutions and increasing regulatory and evidence requirements demand better, value-based access solutions serving patient needs,” said Norbert Farkas, Founder and Managing Partner of Centivis AG. “We are pleased to collaborate with Alira Health. Alira Health’s broad range of tech-enabled consulting and advisory services, complemented by its mission to humanize healthcare, is where our industry is headed.”

About Centivis:

Centivis, founded in 2018, is a boutique (digital) diagnostics market access consulting firm that combines well-proven pharmaceutical market access methodology with specific diagnostics knowledge tested in real-life, industry settings. Centivis has successfully supported leading diagnostics manufacturers, innovative pharmaceuticals, and digital diagnostics scale-ups in launching novel diagnostics solutions, predictive algorithms, and decision support tools in various therapy areas and across technology platforms. Learn more at: www.centivis.com

About Alira Health:

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence. Alira Health’s integrated and multidisciplinary team of over 600 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

Related news

Publications November 22, 2022
External Control Arms: The Way to Go?
The growing implementation of Single Arm Trials (SATs) with External Control Arms (ECAs) has been the subject of heated debate across Europe.
Clinical Trials Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Publications November 8, 2022
Debate sobre los IPT en oncología: buscando puntos de mejora en la evaluación y acceso de los fármacos oncológicos en España
For our Spanish community members, we are glad to share the Debate on IPT in oncology: Looking for points of improvement in the evaluation and access of oncological drugs in Spain.
Oncology Pharma Spain
Multimedia October 27, 2022
RARECast: Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Technology plays a central role in the future of patient empowerment and decentralized clinical trials. Listen to the podcast to learn more.
Decentralized Clinical Trials MedTech
Multimedia October 13, 2022
Exclusive MedTech Webinar Series “Expanding Beyond APAC”
Join this series of webinars to learn about the strategies, challenges, and best practices of scaling beyond the Asia Pacific MedTech market.
MedTech
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.